|
Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimers disease: lead optimization, and proof of concept in a rodent model |
1K08AG071985-01A1 |
|
NIA |
2022 |
|
Astroglial Inflammatory Signaling in Alzheimers Disease |
1K99AG073505-01A1 |
|
NIA |
2022 |
|
Functional deficits in neurovascular coupling in Alzheimers disease |
1K99AG075175-01 |
|
NIA |
2022 |
|
Role of Rab10 in Alzheimers disease |
1K99AG075179-01 |
|
NIA |
2022 |
|
Modulating Alzheimer’s Disease by mTORC1 inhibition to augment lysosomal activity |
1K99AG078342-01 |
|
NIA |
2022 |
|
The Impact of Normative Aging and Alzheimers Disease on Fear based Disorders and Amygdala Dysfunction |
1K99AG078400-01 |
|
NIA |
2022 |
|
Influence of gut on metabolism and cognition in Alzheimers disease. |
1K99AG078402-01 |
|
NIA |
2022 |
|
Delineating how epigenetic regulation of ACVR1C contributes to age and AD-related memory impairments in females and males |
1K99AG078501-01 |
|
NIA |
2022 |
|
Manipulating Neural Oscillations with Non-Invasive Sensory Stimulation for Alzheimers Disease Intervention |
1R01AG069232-01A1 |
|
NIA |
2022 |
|
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures |
1R01AG070895-01A1 |
|
NIA |
2022 |